Works matching IS 15228517 AND DT 2019 AND VI 21 AND IP 2
Results: 17
Old meet new—the path to combination treatments in pediatric low-grade gliomas.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 2, p. 143, doi. 10.1093/neuonc/noy188
- By:
- Publication type:
- Article
Multimodal imaging-defined subregions in newly diagnosed glioblastoma: impact on overall survival.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 2, p. 264, doi. 10.1093/neuonc/noy169
- By:
- Publication type:
- Article
MGMT promoter methylation status testing to guide therapy for glioblastoma: refining the approach based on emerging evidence and current challenges.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 2, p. 167, doi. 10.1093/neuonc/noy132
- By:
- Publication type:
- Article
Uncommon low-grade brain tumors.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 2, p. 151, doi. 10.1093/neuonc/noy151
- By:
- Publication type:
- Article
Supratotal resection in glioma: a systematic review.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 2, p. 179, doi. 10.1093/neuonc/noy166
- By:
- Publication type:
- Article
Sex difference of mutation clonality in diffuse glioma evolution.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 2, p. 201, doi. 10.1093/neuonc/noy154
- By:
- Publication type:
- Article
Response assessment of meningioma: 1D, 2D, and volumetric criteria for treatment response and tumor progression.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 2, p. 234, doi. 10.1093/neuonc/noy126
- By:
- Publication type:
- Article
Outcomes following stereotactic radiosurgery for small to medium-sized brain metastases are exceptionally dependent upon tumor size and prescribed dose.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 2, p. 242, doi. 10.1093/neuonc/noy159
- By:
- Publication type:
- Article
Inhibition of mTORC1 in pediatric low-grade glioma depletes glutathione and therapeutically synergizes with carboplatin.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 2, p. 252, doi. 10.1093/neuonc/noy150
- By:
- Publication type:
- Article
Forthcoming Meetings.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 2, p. 287, doi. 10.1093/neuonc/noz007
- Publication type:
- Article
Glioblastoma: a prognostic value of AMT-PET?
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 2, p. 146, doi. 10.1093/neuonc/noy206
- By:
- Publication type:
- Article
Identification of genomic and molecular traits that present therapeutic vulnerability to HGF-targeted therapy in glioblastoma.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 2, p. 222, doi. 10.1093/neuonc/noy105
- By:
- Publication type:
- Article
Highlights from the Literature.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 2, p. 148, doi. 10.1093/neuonc/noz008
- By:
- Publication type:
- Article
DNA methylation profiling is a method of choice for molecular verification of pediatric WNT-activated medulloblastomas.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 2, p. 214, doi. 10.1093/neuonc/noy155
- By:
- Publication type:
- Article
Dynamic 18 F-FET PET is a powerful imaging biomarker in gadolinium-negative gliomas.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 2, p. 274, doi. 10.1093/neuonc/noy098
- By:
- Publication type:
- Article
Disparities along the glioblastoma clinical trials landscape.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 2, p. 285, doi. 10.1093/neuonc/noy176
- By:
- Publication type:
- Article
Demethylation and epigenetic modification with 5-azacytidine reduces IDH1 mutant glioma growth in combination with temozolomide.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 2, p. 189, doi. 10.1093/neuonc/noy146
- By:
- Publication type:
- Article